PLx Pharma Winddown Corp.: 10-Q filed 2017-08-11
What PLx Pharma Winddown Corp. reported in its quarterly report filed 2017-08-11 (fiscal Q2 2017): 27 published measures, 68 facts as tagged in accession 0001437749-17-014488.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-08-11
- Fiscal period
- fiscal Q2 2017
- Accession
- 0001437749-17-014488 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PLx Pharma Winddown Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 31,807,753 | USD | |
| At 2016-12-31 | 616,488 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 17,090,165 | USD | |
| At 2016-12-31 | 2,935,820 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 14,717,588 | USD | |
| At 2016-12-31 | -2,319,332 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 25,079,590 | USD | |
| At 2016-12-31 | 59,335 | USD | |
| At 2016-06-30 | 385,133 | USD | |
| At 2015-12-31 | 91,657 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -2,236,107 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -3,663,074 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -1,468,127 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -2,369,020 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 90,513 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 375,951 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 375,951 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 20,000 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 20,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -55,648,591 | USD | |
| At 2016-12-31 | -51,985,517 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -920,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -920,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 513,986 | USD | |
| At 2016-12-31 | 426,634 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 406,270 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 1,232,477 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -4,275,003 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -5,620,413 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -1,443,828 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -2,335,357 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 26,876,115 | USD | |
| At 2016-12-31 | 189,854 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 2,760,039 | USD | |
| At 2016-12-31 | 2,735,820 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 2,061,022 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 4,650,954 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 5,996,364 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 1,463,828 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 2,355,357 | USD | 182 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 394,740 | USD | |
| At 2016-12-31 | 116,726 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 626,296 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 754,635 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 13,081 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 53,041 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 8,686,010 | shares | |
| At 2016-12-31 | 4,383,433 | shares |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 2,300,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -3,156,107 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -4,583,074 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -1,468,127 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -2,369,020 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 4,024,658 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 5,241,729 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 1,450,747 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 2,302,316 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 3,161 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 2,486 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 1,118,896 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 1,037,339 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -24,299 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -33,663 | USD | 182 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | -920,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 375,951 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 25,649 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 278,014 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 116,726 | USD | 182 |
Inspect the source
- Entity
- PLx Pharma Winddown Corp. / CIK 0001497504
- Captured
- SEC response SHA-256
d5fa1894253c4a7ca3d44f3b07f2263d07de14ac7e8983994cead4448c203364
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001497504.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))